메뉴 건너뛰기




Volumn 6, Issue 4, 2004, Pages

Renal dysfunction in cirrhosis: Diagnosis, treatment, and prevention

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOGLYCOSIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; CELECOXIB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FUROSEMIDE; MIDODRINE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OCTREOTIDE; ORNIPRESSIN; PENTOXIFYLLINE; TERLIPRESSIN;

EID: 25144459476     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (12)

References (121)
  • 1
    • 0027265413 scopus 로고
    • Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis and ascites
    • Gines A, Escorsell, Gines P, et al. Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis and ascites. Gastroenterology. 1993;105:229-236.
    • (1993) Gastroenterology , vol.105 , pp. 229-236
    • Gines, A.1    Escorsell2    Gines, P.3
  • 2
    • 0000670254 scopus 로고
    • Electrolyte and circulatory changes in terminal liver failure
    • Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure. Lancet. 1956;2:1221-1225.
    • (1956) Lancet , vol.2 , pp. 1221-1225
    • Hecker, R.1    Sherlock, S.2
  • 3
    • 0014684103 scopus 로고
    • Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease
    • Koppel MH, Coburn JN, Mims MM, et al. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease. N Engl J Med. 1969;280:1367-1371.
    • (1969) N. Engl. J. Med. , vol.280 , pp. 1367-1371
    • Koppel, M.H.1    Coburn, J.N.2    Mims, M.M.3
  • 4
    • 0015755728 scopus 로고
    • Recovery from hepatorenal syndrome after orthotopic liver transplantation
    • Iwatsuki S, Popovtzer MM, Corman Jl, et al. Recovery from hepatorenal syndrome after orthotopic liver transplantation. N Engl J Med. 1973;289:1155-1159.
    • (1973) N. Engl. J. Med. , vol.289 , pp. 1155-1159
    • Iwatsuki, S.1    Popovtzer, M.M.2    Corman, J.L.3
  • 5
    • 0030052899 scopus 로고    scopus 로고
    • Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
    • Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 1996;23:164-176.
    • (1996) Hepatology , vol.23 , pp. 164-176
    • Arroyo, V.1    Gines, P.2    Gerbes, A.L.3
  • 6
    • 0037220559 scopus 로고    scopus 로고
    • Ascites and hepatorenal syndrome in cirrhosis: Pathophysiological basis of therapy and current management
    • Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol. 2003;38:S69-S89.
    • (2003) J. Hepatol. , vol.38
    • Arroyo, V.1    Colmenero, J.2
  • 7
    • 0034087697 scopus 로고    scopus 로고
    • Complications of cirrhosis. Renal and circulatory dysfunction lights and shadows in an important clinical problem
    • Arroyo V, Jimenez W. Complications of cirrhosis. Renal and circulatory dysfunction lights and shadows in an important clinical problem. J Hepatol. 2000;32:157-170.
    • (2000) J. Hepatol. , vol.32 , pp. 157-170
    • Arroyo, V.1    Jimenez, W.2
  • 8
    • 0022442745 scopus 로고
    • Influence of the degree of liver failure on systemic and splanchnic hemodynamics and on response to propranonol in patients with cirrhosis
    • Braillon A, Cales P, Valla D, et al. Influence of the degree of liver failure on systemic and splanchnic hemodynamics and on response to propranonol in patients with cirrhosis. Gut. 1986;27:1204-1209.
    • (1986) Gut , vol.27 , pp. 1204-1209
    • Braillon, A.1    Cales, P.2    Valla, D.3
  • 9
    • 0026627932 scopus 로고
    • The hemodynamic status of preascitic cirrhosis: An evaluation under steady-state conditions and after postural change
    • Bernardi M, Di Marco C, Trevisani F, et al. The hemodynamic status of preascitic cirrhosis: an evaluation under steady-state conditions and after postural change. Hepatology. 1992;16:341-346.
    • (1992) Hepatology , vol.16 , pp. 341-346
    • Bernardi, M.1    Di Marco, C.2    Trevisani, F.3
  • 10
    • 0027160767 scopus 로고
    • Renal sodium retention during upright posture in preascitic cirrhosis
    • Bernardi M, Di Marco C, Trevisani F, et al. Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology. 1993;105:188-193.
    • (1993) Gastroenterology , vol.105 , pp. 188-193
    • Bernardi, M.1    Di Marco, C.2    Trevisani, F.3
  • 11
    • 0028961435 scopus 로고
    • Systemic hemodynamic, forearm vascular, renal and humoral response to sustained cardiopulmonary baroreceptor deactivation in cirrhosis
    • Wong F, Logan AG, Blendis LM. Systemic hemodynamic, forearm vascular, renal and humoral response to sustained cardiopulmonary baroreceptor deactivation in cirrhosis. Hepatology. 1995;21:717-724.
    • (1995) Hepatology , vol.21 , pp. 717-724
    • Wong, F.1    Logan, A.G.2    Blendis, L.M.3
  • 12
    • 0026597618 scopus 로고
    • Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension
    • LaVilla G, Salmeron JM, Arroyo V, et al. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology. 1992;102:2114-2119.
    • (1992) Gastroenterology , vol.102 , pp. 2114-2119
    • LaVilla, G.1    Salmeron, J.M.2    Arroyo, V.3
  • 13
    • 0027409331 scopus 로고
    • Glomerular hyperfiltration in patients with well compensated alcoholic cirrhosis
    • Wong F, Massie D, Colman J, Dudley F. Glomerular hyperfiltration in patients with well compensated alcoholic cirrhosis. Gastroenterology. 1993;104:884-889.
    • (1993) Gastroenterology , vol.104 , pp. 884-889
    • Wong, F.1    Massie, D.2    Colman, J.3    Dudley, F.4
  • 14
    • 0023749667 scopus 로고
    • Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
    • Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;1151-1157
    • (1988) Hepatology , pp. 1151-1157
    • Schrier, R.W.1    Arroyo, V.2    Bernardi, M.3    Epstein, M.4    Henriksen, J.H.5    Rodes, J.6
  • 15
    • 0027938229 scopus 로고
    • Hyperdynamic circulation of liver disease 40 years later: Pathophysiology and clinical consequences
    • Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology. 1994;20:1359-1363.
    • (1994) Hepatology , vol.20 , pp. 1359-1363
    • Groszmann, R.J.1
  • 17
    • 0026021317 scopus 로고
    • Increased sympathetic outflow in cirrhosis and ascites: Direct evidence from intraneural recordings
    • Floras JS, Legault L, Morali GA, Hara K, Blendis LM. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann Intern Med. 1991;114:373-380.
    • (1991) Ann. Intern. Med. , vol.114 , pp. 373-380
    • Floras, J.S.1    Legault, L.2    Morali, G.A.3    Hara, K.4    Blendis, L.M.5
  • 18
    • 0035183540 scopus 로고    scopus 로고
    • Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis
    • Pozzi M, Grassi G, Redaelli E, et al. Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis. Hepatology. 2001;34:1113-1118.
    • (2001) Hepatology , vol.34 , pp. 1113-1118
    • Pozzi, M.1    Grassi, G.2    Redaelli, E.3
  • 19
    • 0031160109 scopus 로고    scopus 로고
    • The controversy of the pathophysiology of ascites in cirrhosis
    • Wong F, Girgrah N, Blendis LM. The controversy of the pathophysiology of ascites in cirrhosis. J Gastroenterol Hepatol. 1997;12:437-444.
    • (1997) J. Gastroenterol. Hepatol. , vol.12 , pp. 437-444
    • Wong, F.1    Girgrah, N.2    Blendis, L.M.3
  • 20
    • 0029087768 scopus 로고
    • Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal plasma renin, aldosterone and norepinephrine levels
    • Salo J, Gines A, Anibarro L, et al. Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal plasma renin, aldosterone and norepinephrine levels. Hepatology. 1995;22:479-487.
    • (1995) Hepatology , vol.22 , pp. 479-487
    • Salo, J.1    Gines, A.2    Anibarro, L.3
  • 21
    • 0022466521 scopus 로고
    • Renal function abnormalities prostaglandins and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis
    • Arroyo V, Gines P, Rimola A, et al. Renal function abnormalities prostaglandins and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. Am J Med. 1986;81:104-122.
    • (1986) Am. J. Med. , vol.81 , pp. 104-122
    • Arroyo, V.1    Gines, P.2    Rimola, A.3
  • 22
    • 0027932725 scopus 로고
    • Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites
    • Angeli P, Jimenez W, Arroyo V, et al. Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites. Hepatology. 1994;20:948-954.
    • (1994) Hepatology , vol.20 , pp. 948-954
    • Angeli, P.1    Jimenez, W.2    Arroyo, V.3
  • 23
    • 0029080711 scopus 로고
    • Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis
    • Ros J, Claria J, Jimenez W, et al. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology. 1995;22:915-920.
    • (1995) Hepatology , vol.22 , pp. 915-920
    • Ros, J.1    Claria, J.2    Jimenez, W.3
  • 24
    • 84991133441 scopus 로고
    • The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis
    • Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology. 1994;20:1343-1350.
    • (1994) Hepatology , vol.20 , pp. 1343-1350
    • Bomzon, A.1    Blendis, L.M.2
  • 26
    • 0021132354 scopus 로고
    • Evidence of renal prostaglandins are involved in renal water metabolisim in cirrhosis
    • Perez-Ayoso RM, Arroyo V, Camps J, et al. Evidence of renal prostaglandins are involved in renal water metabolisim in cirrhosis. Kidney Int. 1984;26:72-80.
    • (1984) Kidney Int. , vol.26 , pp. 72-80
    • Perez-Ayoso, R.M.1    Arroyo, V.2    Camps, J.3
  • 27
    • 0033658150 scopus 로고    scopus 로고
    • Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients
    • Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis. 2000;32:605-610.
    • (2000) Dig. Liver Dis. , vol.32 , pp. 605-610
    • Borroni, G.1    Maggi, A.2    Sangiovanni, A.3    Cazzaniga, M.4    Salerno, F.5
  • 28
    • 0025044679 scopus 로고
    • Regulation of the renal circulation
    • Stein J. Regulation of the renal circulation. Kidney Int. 1990;38:571-576.
    • (1990) Kidney Int. , vol.38 , pp. 571-576
    • Stein, J.1
  • 29
    • 0030910810 scopus 로고    scopus 로고
    • Hepatorenal syndrome
    • Moore K. Hepatorenal syndrome. Clin Sci. 1997;92:433-443.
    • (1997) Clin. Sci. , vol.92 , pp. 433-443
    • Moore, K.1
  • 30
    • 0035184982 scopus 로고    scopus 로고
    • Hepatorenal syndrome. Clinical Challenge
    • Wong F, Blendis LM. Hepatorenal syndrome. Clinical Challenge. Hepatology. 2001;34:1242-1251.
    • (2001) Hepatology , vol.34 , pp. 1242-1251
    • Wong, F.1    Blendis, L.M.2
  • 31
    • 0027506821 scopus 로고
    • Effect of dipyridamole on kidney function in cirrhosis
    • Llach J, Gines P, Arroyo V, et al. Effect of dipyridamole on kidney function in cirrhosis. Hepatology. 1993;17;59-64.
    • (1993) Hepatology , vol.17 , pp. 59-64
    • Llach, J.1    Gines, P.2    Arroyo, V.3
  • 32
    • 0006111530 scopus 로고    scopus 로고
    • Arachidonic acid metabolites and the kidney in cirrhosis
    • Arroyo V, ed. Malden, Mass: Blackwell Science
    • Moore KP. Arachidonic acid metabolites and the kidney in cirrhosis. In: Arroyo V, ed. Ascites and renal dysfunction in liver disease. Malden, Mass: Blackwell Science; 1999:249-272.
    • (1999) Ascites and Renal Dysfunction in Liver Disease , pp. 249-272
    • Moore, K.P.1
  • 33
    • 0034770911 scopus 로고    scopus 로고
    • The hepatorenal syndrome
    • Dagher L, Moore K. The hepatorenal syndrome. Gut. 2001;49:729-737.
    • (2001) Gut , vol.49 , pp. 729-737
    • Dagher, L.1    Moore, K.2
  • 34
    • 0030979858 scopus 로고    scopus 로고
    • Reduction in renal blood flow following acute increase in the portal pressure: Evidence for the existence of a hepatorenal reflex in man?
    • Jalan R, Forrest EH, Redhead DN, et al. Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut. 1997;50:664-670.
    • (1997) Gut , vol.50 , pp. 664-670
    • Jalan, R.1    Forrest, E.H.2    Redhead, D.N.3
  • 35
    • 0033931614 scopus 로고    scopus 로고
    • Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study
    • Brensing KA, Textor J, Perz J, et al. Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut. 2000;47:288-295.
    • (2000) Gut , vol.47 , pp. 288-295
    • Brensing, K.A.1    Textor, J.2    Perz, J.3
  • 36
    • 0031949661 scopus 로고    scopus 로고
    • Hepatorenal syndrome: Definition, pathophysiology, clinical features and management
    • Bataller R, Sort P, Gines P, Arroyo V. Hepatorenal syndrome: definition, pathophysiology, clinical features and management. Kidney Int. 1998;53 (suppl 66): S47-S53.
    • (1998) Kidney Int. , vol.53 , Issue.SUPPL. 66
    • Bataller, R.1    Sort, P.2    Gines, P.3    Arroyo, V.4
  • 37
    • 0036098337 scopus 로고    scopus 로고
    • Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment
    • Arroyo V, Guevara M, Gines P. Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment. Gastroenterology. 2002;122:1658-1676.
    • (2002) Gastroenterology , vol.122 , pp. 1658-1676
    • Arroyo, V.1    Guevara, M.2    Gines, P.3
  • 38
    • 0036678368 scopus 로고    scopus 로고
    • Hepatorenal syndrome: Diagnostic accuracy clinical features, and outcome in a tertiary care centre
    • Watt K, Uhanova J, Minuk GY. Hepatorenal syndrome: diagnostic accuracy clinical features, and outcome in a tertiary care centre. Am J Gastroenterol. 2002;97:2046-2050.
    • (2002) Am. J. Gastroenterol. , vol.97 , pp. 2046-2050
    • Watt, K.1    Uhanova, J.2    Minuk, G.Y.3
  • 39
    • 0002029901 scopus 로고
    • The hepatorenal syndrome
    • Epstein M, ed. 2nd Edition. New York: Elsevier Biomedical
    • Papper S. The hepatorenal syndrome. In: Epstein M, ed. The Kidney in Liver Disease. 2nd Edition. New York: Elsevier Biomedical; 1983:87-106.
    • (1983) The Kidney in Liver Disease , pp. 87-106
    • Papper, S.1
  • 40
    • 0027973463 scopus 로고
    • Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis
    • Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994;20:1495-1501.
    • (1994) Hepatology , vol.20 , pp. 1495-1501
    • Follo, A.1    Llovet, J.M.2    Navasa, M.3
  • 41
    • 0036867195 scopus 로고    scopus 로고
    • Liver in sepsis and systemic inflammatory response syndrome
    • Szabo G, Romics L Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis. 2002;6:1045-1066.
    • (2002) Clin. Liver Dis. , vol.6 , pp. 1045-1066
    • Szabo, G.1    Romics Jr., L.2    Frendl, G.3
  • 42
    • 0033527033 scopus 로고    scopus 로고
    • Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis
    • Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403-409.
    • (1999) N. Engl. J. Med. , vol.341 , pp. 403-409
    • Sort, P.1    Navasa, M.2    Arroyo, V.3
  • 43
    • 0033970375 scopus 로고    scopus 로고
    • Upper gastrointestinal bleeding in patients with hepatic cirrhosis: Clinical course and mortality prediction
    • Afessa B, Kublis PS. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol. 2000;95:484-489.
    • (2000) Am. J. Gastroenterol. , vol.95 , pp. 484-489
    • Afessa, B.1    Kublis, P.S.2
  • 44
    • 0034816961 scopus 로고    scopus 로고
    • Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis
    • Cardenas A, Gines P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001:34:671-676.
    • (2001) Hepatology , vol.34 , pp. 671-676
    • Cardenas, A.1    Gines, P.2    Uriz, J.3
  • 45
    • 0030819439 scopus 로고    scopus 로고
    • Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis
    • Salo J, Gines A, Gines P, et al. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. J Hepatol. 1997;27:645-653.
    • (1997) J. Hepatol. , vol.27 , pp. 645-653
    • Salo, J.1    Gines, A.2    Gines, P.3
  • 46
    • 0002626454 scopus 로고    scopus 로고
    • Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study
    • [Abstract]
    • Guevara M, Abecasis R, Jimenez W, et al. Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study [Abstract]; J Hepatol. 2002;36(suppl 1):203.
    • (2002) J. Hepatol. , vol.36 , Issue.SUPPL. 1 , pp. 203
    • Guevara, M.1    Abecasis, R.2    Jimenez, W.3
  • 47
    • 0027528296 scopus 로고
    • Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver
    • Gentilini P, Romanelli RG, La Villa G, et al. Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gastroenterology. 1993;104:588-594.
    • (1993) Gastroenterology , vol.104 , pp. 588-594
    • Gentilini, P.1    Romanelli, R.G.2    La Villa, G.3
  • 48
    • 0035433365 scopus 로고    scopus 로고
    • Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
    • Gonzalez-Abraldes J, Albillos A, Banarez R, et al. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology. 2001;121:389-388.
    • (2001) Gastroenterology , vol.121 , pp. 388-389
    • Gonzalez-Abraldes, J.1    Albillos, A.2    Banarez, R.3
  • 49
    • 0034898990 scopus 로고    scopus 로고
    • Hemodynamic effects of the angiotensin Ii receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
    • Shepke M, Werner E, Biecker E, et al. Hemodynamic effects of the angiotensin Ii receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology. 2001;121:289-395.
    • (2001) Gastroenterology , vol.121 , pp. 289-395
    • Shepke, M.1    Werner, E.2    Biecker, E.3
  • 50
    • 0033060562 scopus 로고    scopus 로고
    • Improvement in renal function in hepatorenal syndrome with N-acetylcysteine
    • Holt S, Goodier D, Marley R, et al. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet. 1999;353:294-295.
    • (1999) Lancet , vol.353 , pp. 294-295
    • Holt, S.1    Goodier, D.2    Marley, R.3
  • 51
    • 0032943093 scopus 로고    scopus 로고
    • Acute cholestasis-induced renal failure: Effects of antioxidants and ligands for the thromboxane A2 receptor
    • Holt S, Marley R, Fernando B, et al. Acute cholestasis-induced renal failure: effects of antioxidants and ligands for the thromboxane A2 receptor. Kidney Int. 1999;55:271-277.
    • (1999) Kidney Int. , vol.55 , pp. 271-277
    • Holt, S.1    Marley, R.2    Fernando, B.3
  • 52
    • 0344256499 scopus 로고    scopus 로고
    • Hepatorenal syndrome
    • Gines P, Guevara M, Arroyo V, et al. Hepatorenal syndrome. Lancet. 2003;362:1819-27.
    • (2003) Lancet , vol.362 , pp. 1819-1827
    • Gines, P.1    Guevara, M.2    Arroyo, V.3
  • 53
    • 0032983535 scopus 로고    scopus 로고
    • Renal failure in liver disease
    • Eckardt KU. Renal failure in liver disease. Intensive Care Med. 1999;25:5-14.
    • (1999) Intensive Care Med. , vol.25 , pp. 5-14
    • Eckardt, K.U.1
  • 54
    • 0036867319 scopus 로고    scopus 로고
    • Liver and kidney disease
    • Wong F. Liver and kidney disease. Clin Liver Dis. 2002;6:981-1011.
    • (2002) Clin. Liver Dis. , vol.6 , pp. 981-1011
    • Wong, F.1
  • 55
    • 0036192392 scopus 로고    scopus 로고
    • Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation (Part I)
    • Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation (Part I). Liver Transpl. 2002;8:91-109.
    • (2002) Liver Transpl. , vol.8 , pp. 91-109
    • Davis, C.L.1    Gonwa, T.A.2    Wilkinson, A.H.3
  • 56
    • 0036434909 scopus 로고    scopus 로고
    • Significance of the fractional excretion of urea in the differential diagnosis or acute renal failure
    • Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis or acute renal failure. Kidney Int. 2002;62:2223-2229.
    • (2002) Kidney Int. , vol.62 , pp. 2223-2229
    • Carvounis, C.P.1    Nisar, S.2    Guro-Razuman, S.3
  • 57
    • 0036210275 scopus 로고    scopus 로고
    • Terlipressin in patients with cirrhosis and Type 1 hepatorenal syndrome: A retrospective multicenter study
    • Moreau R, Durand F, Poynrd T, et al. Terlipressin in patients with cirrhosis and Type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology. 2002;122:923-930.
    • (2002) Gastroenterology , vol.122 , pp. 923-930
    • Moreau, R.1    Durand, F.2    Poynrd, T.3
  • 58
    • 0033180281 scopus 로고    scopus 로고
    • Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis
    • Deschenes M, Villeneuve J. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol. 1999;94:2193-2197.
    • (1999) Am. J. Gastroenterol. , vol.94 , pp. 2193-2197
    • Deschenes, M.1    Villeneuve, J.2
  • 59
    • 0021814770 scopus 로고
    • Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage
    • Rimola A, Bory F, Teres J, et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology. 1985;5:463-467.
    • (1985) Hepatology , vol.5 , pp. 463-467
    • Rimola, A.1    Bory, F.2    Teres, J.3
  • 60
    • 0026781087 scopus 로고
    • Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage
    • Soriano G, Guarner C, Tomas A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology. 1992;103:1267-1272.
    • (1992) Gastroenterology , vol.103 , pp. 1267-1272
    • Soriano, G.1    Guarner, C.2    Tomas, A.3
  • 61
    • 0028341096 scopus 로고
    • Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage
    • Blaise M, Pateron D, Trinchet J, et al. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1994;20:34-38.
    • (1994) Hepatology , vol.20 , pp. 34-38
    • Blaise, M.1    Pateron, D.2    Trinchet, J.3
  • 62
    • 0029829650 scopus 로고    scopus 로고
    • Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection
    • Pauwels A, Mostefa-Kara N, Debenes B, et al. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology. 1996;24:802-806.
    • (1996) Hepatology , vol.24 , pp. 802-806
    • Pauwels, A.1    Mostefa-Kara, N.2    Debenes, B.3
  • 63
    • 0032105450 scopus 로고    scopus 로고
    • The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding
    • Hsieh W, Lin H, Hwang S, et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol. 1998;93:962-966.
    • (1998) Am. J. Gastroenterol. , vol.93 , pp. 962-966
    • Hsieh, W.1    Lin, H.2    Hwang, S.3
  • 64
    • 0032993780 scopus 로고    scopus 로고
    • Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis
    • Bernard B, Grange J, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655-1661.
    • (1999) Hepatology , vol.29 , pp. 1655-1661
    • Bernard, B.1    Grange, J.2    Khac, E.N.3
  • 65
    • 25144448943 scopus 로고    scopus 로고
    • Sepsis in cirrhosis
    • in press
    • Wong F, Bernardi M, Balk R, et al. Sepsis in cirrhosis. Gut. 2004; in press.
    • (2004) Gut
    • Wong, F.1    Bernardi, M.2    Balk, R.3
  • 66
    • 0031979978 scopus 로고    scopus 로고
    • Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage
    • Goulis J, Armonis A, Patch D, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998;27:1207-1212.
    • (1998) Hepatology , vol.27 , pp. 1207-1212
    • Goulis, J.1    Armonis, A.2    Patch, D.3
  • 67
    • 0025151559 scopus 로고
    • Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
    • Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12:716-724.
    • (1990) Hepatology , vol.12 , pp. 716-724
    • Gines, P.1    Rimola, A.2    Planas, R.3
  • 68
    • 0023907437 scopus 로고
    • Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis
    • Gines P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 1988;84:1493-1502.
    • (1988) Gastroenterology , vol.84 , pp. 1493-1502
    • Gines, P.1    Tito, L.2    Arroyo, V.3
  • 69
    • 10144248967 scopus 로고    scopus 로고
    • Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis
    • Gines P, Fernandez-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996;111:1002-1010.
    • (1996) Gastroenterology , vol.111 , pp. 1002-1010
    • Gines, P.1    Fernandez-Esparrach, G.2    Monescillo, A.3
  • 70
    • 0022486868 scopus 로고
    • Rapid diuresis in patients with ascites from chronic liver disease: The importance of peripheral edema
    • Pockros PJ, Reynolds TB. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology. 1986;90:1827-1833.
    • (1986) Gastroenterology , vol.90 , pp. 1827-1833
    • Pockros, P.J.1    Reynolds, T.B.2
  • 71
    • 25144446617 scopus 로고    scopus 로고
    • Aminoglycoside toxicity in cirrhosis. Value of urinary beta-2 microglobulin to discriminate functional renal failure from acute tubular damage
    • Cabrera J, Arroyo V, Ballesta AM, et al. Aminoglycoside toxicity in cirrhosis. Value of urinary beta-2 microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology. 1996;111:1002-1010.
    • (1996) Gastroenterology , vol.111 , pp. 1002-1010
    • Cabrera, J.1    Arroyo, V.2    Ballesta, A.M.3
  • 72
    • 0035184982 scopus 로고    scopus 로고
    • New challenge of hepatorenal syndrome: Prevention and treatment
    • Wong F, Blendis L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology. 2001;34:1242-1251.
    • (2001) Hepatology , vol.34 , pp. 1242-1251
    • Wong, F.1    Blendis, L.2
  • 73
    • 84942475979 scopus 로고
    • Response to dopamine hydrochloride in the hepatorenal syndrome
    • Bennett WM, Keeffe E, Melnyk C, et al. Response to dopamine hydrochloride in the hepatorenal syndrome. Arch Intern Med. 1975;135:964-971.
    • (1975) Arch. Intern. Med. , vol.135 , pp. 964-971
    • Bennett, W.M.1    Keeffe, E.2    Melnyk, C.3
  • 74
    • 0025945029 scopus 로고
    • Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis
    • Bacq Y, Gaudin C, Hadengue A, et al. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology. 1991;14:483-487.
    • (1991) Hepatology , vol.14 , pp. 483-487
    • Bacq, Y.1    Gaudin, C.2    Hadengue, A.3
  • 75
    • 0036326383 scopus 로고    scopus 로고
    • Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study
    • Duvoux C, Zanditenas D, Hezode C, et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology. 2002;36:374-380.
    • (2002) Hepatology , vol.36 , pp. 374-380
    • Duvoux, C.1    Zanditenas, D.2    Hezode, C.3
  • 76
    • 0026576720 scopus 로고
    • Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion
    • Badalamenti S, Borroni G, Lorenzano E, Incerti P, Salerno F. Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion. Hepatology. 1992;15:824-829.
    • (1992) Hepatology , vol.15 , pp. 824-829
    • Badalamenti, S.1    Borroni, G.2    Lorenzano, E.3    Incerti, P.4    Salerno, F.5
  • 77
    • 0033065188 scopus 로고    scopus 로고
    • Reversal of type I hepatorenal syndrome with the administration of midodrine and octreotide
    • Angeli P, Volpin R, Gerunda G, et al. Reversal of type I hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology. 1999;29:1690-1697.
    • (1999) Hepatology , vol.29 , pp. 1690-1697
    • Angeli, P.1    Volpin, R.2    Gerunda, G.3
  • 78
    • 3042696433 scopus 로고    scopus 로고
    • The use of midodrine, octreotide and transjugular intrahepatic portosystemic stent shunt in the treatment of cirrhotic patients with ascites and renal dysfunction including hepatorenal syndrome
    • Wong F, Pantea L, Sniderman K. The use of midodrine, octreotide and transjugular intrahepatic portosystemic stent shunt in the treatment of cirrhotic patients with ascites and renal dysfunction including hepatorenal syndrome. Hepatology. 2004;40:55-64.
    • (2004) Hepatology , vol.40 , pp. 55-64
    • Wong, F.1    Pantea, L.2    Sniderman, K.3
  • 79
    • 0037784209 scopus 로고    scopus 로고
    • Octreotide in hepatorenal syndrome: A randomized, double-blind, placebo-controlled, crossover study
    • Pomier-Layrargues G, Paquin SC, Hassoun Z, et al. Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study. Hepatology. 2003;38:238-243.
    • (2003) Hepatology , vol.38 , pp. 238-243
    • Pomier-Layrargues, G.1    Paquin, S.C.2    Hassoun, Z.3
  • 80
    • 0025203997 scopus 로고
    • Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration
    • Fevery J, Van Cutsem E, Nevens F, et al. Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration. J Hepatol. 1990;11:153-158.
    • (1990) J. Hepatol. , vol.11 , pp. 153-158
    • Fevery, J.1    Van Cutsem, E.2    Nevens, F.3
  • 81
    • 0027397891 scopus 로고
    • Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure
    • Gines A, Salmeron JM, Gines P, et al. Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. J Hepatol. 1993;17:220-226.
    • (1993) J. Hepatol. , vol.17 , pp. 220-226
    • Gines, A.1    Salmeron, J.M.2    Gines, P.3
  • 82
    • 0024501094 scopus 로고
    • Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis
    • Lenz K, Hortnagl H, Druml W, et al. Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. Gut. 1989;30:90-96.
    • (1989) Gut , vol.30 , pp. 90-96
    • Lenz, K.1    Hortnagl, H.2    Druml, W.3
  • 83
    • 0025945527 scopus 로고
    • Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor
    • Lenz K, Hortnagl H, Druml W, et al. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology. 1991;101:1060-1067.
    • (1991) Gastroenterology , vol.101 , pp. 1060-1067
    • Lenz, K.1    Hortnagl, H.2    Druml, W.3
  • 84
    • 0030444514 scopus 로고    scopus 로고
    • Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome
    • Salo J, Gines A, Quer JC, et al. Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome. J Hepatol. 1996;25:916-923.
    • (1996) J. Hepatol. , vol.25 , pp. 916-923
    • Salo, J.1    Gines, A.2    Quer, J.C.3
  • 85
    • 0032885451 scopus 로고    scopus 로고
    • Gerbes Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine
    • Gulberg V, Bilzer M, Gerbes. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology. 1999;30:870-875.
    • (1999) Hepatology , vol.30 , pp. 870-875
    • Gulberg, V.1    Bilzer, M.2
  • 86
    • 0031962226 scopus 로고    scopus 로고
    • Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
    • Guevara M, Gines P, Fernandez-Esparrach G, et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology. 1998;27:35-41.
    • (1998) Hepatology , vol.27 , pp. 35-41
    • Guevara, M.1    Gines, P.2    Fernandez-Esparrach, G.3
  • 87
    • 0033982045 scopus 로고    scopus 로고
    • Central and systemic hemodynamic effects of terlipressin in portal hypertensive patients
    • Moller S, Hansen EF, Becker U, et al. Central and systemic hemodynamic effects of terlipressin in portal hypertensive patients. Liver. 2000;20:51-59.
    • (2000) Liver , vol.20 , pp. 51-59
    • Moller, S.1    Hansen, E.F.2    Becker, U.3
  • 88
    • 0032191718 scopus 로고    scopus 로고
    • Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome
    • Hadengue A, Gadano A, Moreau R, et al. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol. 1998;29:565-570.
    • (1998) J. Hepatol. , vol.29 , pp. 565-570
    • Hadengue, A.1    Gadano, A.2    Moreau, R.3
  • 89
    • 0033916288 scopus 로고    scopus 로고
    • Terlipressin plus albumin infusion: An effective and safe therapy of hepatorenal syndrome
    • Uriz J, Gines P, Cardenas A, et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol. 2000;33:43-48.
    • (2000) J. Hepatol. , vol.33 , pp. 43-48
    • Uriz, J.1    Gines, P.2    Cardenas, A.3
  • 90
    • 0037300902 scopus 로고    scopus 로고
    • Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo-controlled clinical trial
    • Solanki P, Chawla A, Garg R, et al. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol. 2003;18:152-156.
    • (2003) J. Gastroenterol. Hepatol. , vol.18 , pp. 152-156
    • Solanki, P.1    Chawla, A.2    Garg, R.3
  • 91
    • 0036174425 scopus 로고    scopus 로고
    • Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: Results of a multicentre pilot study
    • Halimi C, Bonnard P, Bernard B, et al. Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study. Eur J Gastroenterol Hepatol. 2002;14:153-158.
    • (2002) Eur. J. Gastroenterol. Hepatol. , vol.14 , pp. 153-158
    • Halimi, C.1    Bonnard, P.2    Bernard, B.3
  • 92
    • 0036787604 scopus 로고    scopus 로고
    • Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study
    • Ortega R, Gines P, Uriz J, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36:941-948.
    • (2002) Hepatology , vol.36 , pp. 941-948
    • Ortega, R.1    Gines, P.2    Uriz, J.3
  • 93
    • 0041314005 scopus 로고    scopus 로고
    • Terlipressin plus hydroxy-ethyl starch infusion: An effective treatment for hepatorenal syndrome
    • Saner FH, Fruhauf NR, Schafers RF, et al. Terlipressin plus hydroxy-ethyl starch infusion: an effective treatment for hepatorenal syndrome. Eur J Gastroenterol Hepatol. 2003;15:925-927.
    • (2003) Eur. J. Gastroenterol. Hepatol. , vol.15 , pp. 925-927
    • Saner, F.H.1    Fruhauf, N.R.2    Schafers, R.F.3
  • 94
    • 0026490970 scopus 로고
    • Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome
    • Moore K, Wendon J, Frazer M, et al. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med. 1992;327:1774-1778.
    • (1992) N. Engl. J. Med. , vol.327 , pp. 1774-1778
    • Moore, K.1    Wendon, J.2    Frazer, M.3
  • 95
    • 0036137009 scopus 로고    scopus 로고
    • Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure
    • Anand R, Harry D, Holt S, et al. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut. 2002;50:111-117.
    • (2002) Gut , vol.50 , pp. 111-117
    • Anand, R.1    Harry, D.2    Holt, S.3
  • 96
    • 0033804058 scopus 로고    scopus 로고
    • Plasma levels of endothelin-1 in patients with the hepatorenal syndrome after successful liver transplantation
    • Bachmann-Brandt S, Bittner I, Neuhaus P, et al. Plasma levels of endothelin-1 in patients with the hepatorenal syndrome after successful liver transplantation. Transpl Int. 2000;13:357-362.
    • (2000) Transpl. Int. , vol.13 , pp. 357-362
    • Bachmann-Brandt, S.1    Bittner, I.2    Neuhaus, P.3
  • 97
    • 0029786171 scopus 로고    scopus 로고
    • Amelioration of hepatorenal syndrome with selective endothelin-A antagonist
    • Soper CP, Latif AB, Bending MR. Amelioration of hepatorenal syndrome with selective endothelin-A antagonist. Lancet. 1996;347:1842-1843.
    • (1996) Lancet , vol.347 , pp. 1842-1843
    • Soper, C.P.1    Latif, A.B.2    Bending, M.R.3
  • 98
    • 0034465251 scopus 로고    scopus 로고
    • Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
    • Akriviadis E, Botla R, Briggs W, et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:1637-1648.
    • (2000) Gastroenterology , vol.119 , pp. 1637-1648
    • Akriviadis, E.1    Botla, R.2    Briggs, W.3
  • 99
    • 0035671695 scopus 로고    scopus 로고
    • Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system
    • Mitzner SR, Klammt S, Peszynski P, et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher. 2001;5:417-422.
    • (2001) Ther. Apher. , vol.5 , pp. 417-422
    • Mitzner, S.R.1    Klammt, S.2    Peszynski, P.3
  • 100
    • 0034109694 scopus 로고    scopus 로고
    • Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial
    • Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl. 2000;6:277-286.
    • (2000) Liver Transpl. , vol.6 , pp. 277-286
    • Mitzner, S.R.1    Stange, J.2    Klammt, S.3
  • 101
    • 0027957930 scopus 로고
    • The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding
    • Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994;330:165-171.
    • (1994) N. Engl. J. Med. , vol.330 , pp. 165-171
    • Rossle, M.1    Haag, K.2    Ochs, A.3
  • 102
    • 0028913420 scopus 로고
    • Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters
    • Quiroga J, Sangro B, N ez M. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology. 1995:21;986-994.
    • (1995) Hepatology , vol.21 , pp. 986-994
    • Quiroga, J.1    Sangro, B.2    Sangro, N.3    Sangro, M.4
  • 103
    • 0031042630 scopus 로고    scopus 로고
    • The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt
    • Wong F, Sniderman K, Liu P, et al. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology. 1997;112:899-907.
    • (1997) Gastroenterology , vol.112 , pp. 899-907
    • Wong, F.1    Sniderman, K.2    Liu, P.3
  • 104
    • 0031721408 scopus 로고    scopus 로고
    • Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: Comparison of patients with ascites, with refractory ascites, or without Ascites
    • Gerbes AL, Gulberg V, Waggershauser T. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: Comparison of patients with ascites, with refractory ascites, or without Ascites. Hepatology. 1998;28:683-688.
    • (1998) Hepatology , vol.28 , pp. 683-688
    • Gerbes, A.L.1    Gulberg, V.2    Waggershauser, T.3
  • 105
    • 0033104831 scopus 로고    scopus 로고
    • Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunt for refractory ascites
    • Wong W, Liu P, Blendis L, et al. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunt for refractory ascites. Am J Med. 1999;106:315-322.
    • (1999) Am. J. Med. , vol.106 , pp. 315-322
    • Wong, W.1    Liu, P.2    Blendis, L.3
  • 106
    • 0042429572 scopus 로고    scopus 로고
    • Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
    • Guevara M, Gines P, Bandi JC, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology. 1998;28:416-422.
    • (1998) Hepatology , vol.28 , pp. 416-422
    • Guevara, M.1    Gines, P.2    Bandi, J.C.3
  • 107
    • 0031034917 scopus 로고    scopus 로고
    • Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS)
    • Martinet JP, Fenyves D, Legault L, et al. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS). Dig Dis Sci. 1997;42:161-166.
    • (1997) Dig. Dis. Sci. , vol.42 , pp. 161-166
    • Martinet, J.P.1    Fenyves, D.2    Legault, L.3
  • 108
    • 0027252834 scopus 로고
    • Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency
    • Lake JR, Ring E, LaBerge J, et al. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant Proc. 1993;25:1766-1767.
    • (1993) Transplant Proc. , vol.25 , pp. 1766-1767
    • Lake, J.R.1    Ring, E.2    LaBerge, J.3
  • 109
    • 0029010937 scopus 로고
    • Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt
    • Spahr L, Fenyves D, Nguyen VV, et al. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 1995;90:1169-1171.
    • (1995) Am. J. Gastroenterol. , vol.90 , pp. 1169-1171
    • Spahr, L.1    Fenyves, D.2    Nguyen, V.V.3
  • 110
    • 0036892328 scopus 로고    scopus 로고
    • Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis
    • Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839-1847.
    • (2002) Gastroenterology , vol.123 , pp. 1839-1847
    • Gines, P.1    Uriz, J.2    Calahorra, B.3
  • 111
    • 0029001750 scopus 로고
    • The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites
    • Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites. N Engl J Med. 1995;332:1192-1197.
    • (1995) N. Engl. J. Med. , vol.332 , pp. 1192-1197
    • Ochs, A.1    Rossle, M.2    Haag, K.3
  • 112
    • 0033923689 scopus 로고    scopus 로고
    • Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure
    • Michl P, Gulberg V, Blitzer M, et al. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure. Scan J Gastroenterol. 2000;35:654-658.
    • (2000) Scan. J. Gastroenterol. , vol.35 , pp. 654-658
    • Michl, P.1    Gulberg, V.2    Blitzer, M.3
  • 113
    • 0342803192 scopus 로고    scopus 로고
    • A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites
    • Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701-1707.
    • (2000) N. Engl. J. Med. , vol.342 , pp. 1701-1707
    • Rossle, M.1    Ochs, A.2    Gulberg, V.3
  • 114
    • 0037370136 scopus 로고    scopus 로고
    • The North American Study of Treatment for Refractory Ascites (NASTRA)
    • Sanyal AJ, Genning C, Reddy RK, et al. The North American Study of Treatment for Refractory Ascites (NASTRA). Gastroenterology. 2003;124:634-641.
    • (2003) Gastroenterology , vol.124 , pp. 634-641
    • Sanyal, A.J.1    Genning, C.2    Reddy, R.K.3
  • 115
    • 9444257018 scopus 로고    scopus 로고
    • Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial
    • Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol. 1996;25:135-144.
    • (1996) J. Hepatol. , vol.25 , pp. 135-144
    • Lebrec, D.1    Giuily, N.2    Hadengue, A.3
  • 116
    • 4544387932 scopus 로고    scopus 로고
    • A randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites
    • in press
    • Salerno F, Merli M, Riggio O. et al. A randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004; in press.
    • (2004) Hepatology
    • Salerno, F.1    Merli, M.2    Riggio, O.3
  • 117
    • 0034106289 scopus 로고    scopus 로고
    • A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
    • Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31;864-871.
    • (2000) Hepatology , vol.31 , pp. 864-871
    • Malinchoc, M.1    Kamath, P.S.2    Gordon, F.D.3
  • 118
    • 0033915685 scopus 로고    scopus 로고
    • Improving prognosis in hepatorenal syndrome
    • McCormick PA. Improving prognosis in hepatorenal syndrome. Gut. 2000;47:166-167.
    • (2000) Gut , vol.47 , pp. 166-167
    • McCormick, P.A.1
  • 119
    • 0028363114 scopus 로고
    • Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study
    • Sanyal AJ, Freedman AM, Shiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study. Hepatology. 1994;20:46-55.
    • (1994) Hepatology , vol.20 , pp. 46-55
    • Sanyal, A.J.1    Freedman, A.M.2    Shiffman, M.L.3
  • 120
    • 0026096518 scopus 로고
    • Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients
    • Gonwa TA, Morris CA, Goldstein RM, et al. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation. 1991;51:428-430.
    • (1991) Transplantation , vol.51 , pp. 428-430
    • Gonwa, T.A.1    Morris, C.A.2    Goldstein, R.M.3
  • 121
    • 0028912110 scopus 로고
    • Impact of pretransplant renal function on survival after liver transplantation
    • Gonwa TA, Klintmalm GB, Levy M, et al. Impact of pretransplant renal function on survival after liver transplantation. Transplantation. 1995;59:361-365.
    • (1995) Transplantation , vol.59 , pp. 361-365
    • Gonwa, T.A.1    Klintmalm, G.B.2    Levy, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.